Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors
Introduction: Defects in immunologic self-tolerance result in an increased risk for development of paraneoplastic autoimmune diseases (ADs) and immune-mediated toxicity in response to immune stimulation in individuals with thymic epithelial tumors (TETs). We conducted a survey to evaluate the tolera...
Main Authors: | Madison Ballman, BA, Shannon Swift, RN, BSN, Cristina Mullenix, DNP, FNP-BC, Yvonne Mallory, RN, BSN, Chen Zhao, MD, Eva Szabo, MD, Meenakshi Shelat, PharmD, Susan Sansone, BA, Seth M. Steinberg, PhD, Meredith J. McAdams, MD, Arun Rajan, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | JTO Clinical and Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666364321000886 |
Similar Items
-
Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors
by: Thomas Yang Sun, MD, MHS, et al.
Published: (2023-04-01) -
Thymoma and thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic analysis of 18 cases
by: Xuxia Shen, et al.
Published: (2018-06-01) -
Current Treatment Approaches for Thymic Epithelial Tumors
by: Alfredo Tartarone, et al.
Published: (2023-05-01) -
Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors
by: Surbhi Singhal, MD, et al.
Published: (2022-05-01) -
Chemotherapy in the treatment of thymic tumors
by: Marcello Tiseo, et al.
Published: (2011-12-01)